Paloma Partners’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Paloma Partners’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,775,000	Closed	-$1.36M	–	1214
2023 Q1	$1.36M	Buy	+3,775,000	New	+$3.38M	0.3%	312
2022 Q2	–	Sell	-47,591	Closed	-$111K	–	2026
2022 Q1	$111K	Buy	+47,591	New	+$148K	0.01%	1556
2019 Q2	–	Sell	-38,300	Closed	-$182K	–	2307
2019 Q1	$182K	Buy	38,300 +24,000	+168%	+$63K	0.01%	1540
2018 Q4	$34K	Buy	+14,300	New	+$46.7K	﹤0.01%	1176
2017 Q3	–	Sell	-93,900	Closed	-$188K	–	2556
2017 Q2	$188K	Buy	+93,900	New	+$183K	0.01%	2015

Other funds holding SRNE

SlateStone Wealth Jupiter, Florida $1.21B AUM 21.86% 1-Year Est. Return

KLCM Advisors Milwaukee, Wisconsin $1.15B AUM 34.45% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Russell Investments Group

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return